BOQ:ASXBank of Queensland Limited Analysis
Data as of 2026-07-05 - not real-time
A$6.18
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Bank of Queensland is trading at $6.18, which sits below its 20‑day SMA of 6.25 and 50‑day SMA of 6.30, indicating a short‑term downtrend. The MACD histogram is negative and the MACD line trails its signal, reinforcing the bearish technical bias, while the RSI at 42.8 suggests momentum is still neutral but not yet oversold. Volume has been decreasing, and the price is hovering just above the identified support at $5.91, with resistance near $6.41, leaving limited upside of roughly 2% based on the computed upside/downside metric. Fundamentally, the stock appears cheap on a price‑to‑book basis (0.69x) and a DCF fair value of $12.74, more than double the current market price, but its trailing P/E of 41.2 is far above the industry average of 17.5, signaling overvaluation on earnings multiples. Dividend yield is attractive at 6.47%, yet the payout ratio exceeds 250%, casting doubt on the sustainability of that income stream.
The bank carries a low beta of 0.40 and a 30‑day volatility of 15.4%, implying modest market risk, but a high net‑debt position (total debt $16.7 bn versus cash $4.9 bn) and a meager ROE of 1.6% raise concerns about financial resilience. Analyst consensus rates the stock as "underperform" and the recommendation key aligns with a modest upside potential of only 1.8%, suggesting that any price appreciation would be limited in the near term.
The bank carries a low beta of 0.40 and a 30‑day volatility of 15.4%, implying modest market risk, but a high net‑debt position (total debt $16.7 bn versus cash $4.9 bn) and a meager ROE of 1.6% raise concerns about financial resilience. Analyst consensus rates the stock as "underperform" and the recommendation key aligns with a modest upside potential of only 1.8%, suggesting that any price appreciation would be limited in the near term.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and decreasing volume
- Limited upside of ~2% and support near $5.91
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- DCF fair value suggests upside if fundamentals improve
- Low beta and moderate volatility
- High dividend yield but unsustainable payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant discount to DCF valuation
- Cheap price‑to‑book multiple
- Potential for earnings expansion reflected in forward P/E of 11.2
Key Metrics & Analysis
Financial Health
Revenue Growth2.00%
Profit Margin5.89%
P/E Ratio41.2
ROE1.64%
ROA0.10%
P/B Ratio0.7
Op. Cash FlowA$2.0B
Industry P/E17.5
Technical Analysis
TrendBearish
RSI42.8
SupportA$5.91
ResistanceA$6.41
MA 20A$6.25
MA 50A$6.30
MA 200A$6.71
MACDBearish
VolumeDecreasing
Fear & Greed Index93.2
Valuation
Fair ValueA$12.74
Target PriceA$6.29
Upside/Downside1.80%
GradeUndervalued
TypeValue
Dividend Yield6.47%
Risk Assessment
Beta0.40
Volatility15.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.